跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALBUREX 5 AU Human Albumin 50 g/L (5% w/v) 250 mL solution for intravenous infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
ALBUREX 5 AU Human Albumin 50 g/L (5% w/v) 250 mL solution for intravenous infusion vial
Approved
STANDARD
ALBUREX 5 AU Human Albumin 50 g/L (5% w/v) 250 mL solution for intravenous infusion vial
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b188f2a7ba2a655d
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
b188f2a7ba2a655d
Product Name
ALBUREX 5 AU Human Albumin 50 g/L (5% w/v) 250 mL solution for intravenous infusion vial
Artg Id
327950
Artg Name
ALBUREX 5 AU Human Albumin 50 g/L (5% w/v) 250 mL solution for intravenous infusion vial
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2020-07-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01914-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-01908-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b188f2a7ba2a655d
Type
Standard
Back to TGA Approvals